<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03968783</url>
  </required_header>
  <id_info>
    <org_study_id>Cesarean suture study</org_study_id>
    <nct_id>NCT03968783</nct_id>
  </id_info>
  <brief_title>The Effect of Suturing Material on Scar Healing</brief_title>
  <official_title>The Effect of Suturing Material on Scar Healing; a Randomised Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bezmialem Vakif University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bezmialem Vakif University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We want to compare the effects of 2 suture materials (monofilament and multifilament) on
      healing of the uterine scar after a cesarean delivery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cesarean section (CS) is the most common type of obstetric surgery. When medically justified,
      CS can effectively prevent maternal and perinatal mortality and morbidity however, there are
      many short and long-term complications of CS. One of the most common complications is the CS
      scar defect. CS scar defects can develop after transverse incision of the lower uterine
      segment, which may result in prolonged postmenstrual bleeding, spotting, pelvic pain, and
      infertility. Suture material is an essential part of any major surgery, serving to hold
      opposing tissues together and accelerate the healing process, resulting in decreased scarring
      of the affected areas. We sought to evaluate the effects of different synthetic absorbable
      suture materials on cesarean scar defect formation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 27, 2019</start_date>
  <completion_date type="Actual">January 27, 2020</completion_date>
  <primary_completion_date type="Actual">July 27, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The healing ratio</measure>
    <time_frame>6 months</time_frame>
    <description>Six months after the operation, the integrity of the cesarean scar at the uterine incision site will be assessed by hydrosonography. The healing ratio will be calculated as the thickness of the residual myometrium covering the defect, divided by the sum of the thickness of the residual myometrium covering the defect and the height of the wedge-shaped defect.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>blood loss</measure>
    <time_frame>24 hours</time_frame>
    <description>The hemoglobin and hematocrit values will be measured 24 hours after CS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>additional sutures</measure>
    <time_frame>2 hours</time_frame>
    <description>number of additional hemostatic sutures</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">95</enrollment>
  <condition>Wound Heal</condition>
  <condition>Cesarean Section Complications</condition>
  <condition>Cesarean Wound Disruption</condition>
  <condition>Suture Related Complication</condition>
  <arm_group>
    <arm_group_label>Monofilament suture</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>continuous double-layer unlocked suturing with 1.0 monofilament synthetic absorbable suture</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Multifilament suture</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>continuous double-layer unlocked suturing with 1.0 multifilament synthetic absorbable suture</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Monofilament suture</intervention_name>
    <description>1.0 monofilament synthetic absorbable suture for closure of the low transverse uterine incision</description>
    <arm_group_label>Monofilament suture</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multifilament suture</intervention_name>
    <description>1.0 multifilament synthetic absorbable suture for closure of the low transverse uterine incision</description>
    <arm_group_label>Multifilament suture</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  singleton pregnancy at term &gt;37 weeks of gestational age

        Exclusion Criteria:

          -  history of previous cesarean section

          -  history of previous uterine surgery

          -  multiple gestation, placenta previa, polyhydramnious, fetal macrosomia

          -  uterine atony history

          -  gestational diabetes mellitus, gestational hypertension, preeclampsia, current or
             previous history of heart disease, liver, renal disorders or known coagulopath

          -  active labor (with regular uterine contractions and cervical dilatation &gt;4 cm
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bezmialem VakÄ±f University Hospital</name>
      <address>
        <city>Istanbul</city>
        <zip>34093</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>May 28, 2019</study_first_submitted>
  <study_first_submitted_qc>May 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2019</study_first_posted>
  <last_update_submitted>February 10, 2020</last_update_submitted>
  <last_update_submitted_qc>February 10, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cesarean section</keyword>
  <keyword>scar heal</keyword>
  <keyword>isthmocele</keyword>
  <keyword>suture material</keyword>
  <keyword>saline infusion sonography</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

